Test Price
2,800 AED✅ Home Collection Available
EFCAB13 Gene Autism Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين EFCAB13 لتشخيص طيف التوحد في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
ملخص تنفيذي: يقدم هذا التحليل الجيني المتقدم تسلسل الجين الكامل باستخدام تقنية الجيل التالي المعتمدة عالمياً، بدقة تشخيصية تفوق 99.9% وفق معايير مختبر مرخص من هيئة الصحة بدبي. تشمل الخدمة استشارة وراثية شاملة، وسحب عينات منزلية بمواصفات النقل المبرد ISO، وتوجيه طبي هاتفي بعد النتيجة لضمان الفهم السريري الكامل. للتحقق المباشر من التغطية التأمينية، تواصلوا عبر الواتساب على الرقم 5488731 54 971+.
99.9% Diagnostic Sensitivity via NGS Technology processed in ISO 9001:2015 Certified Laboratory (Cert: INT/EGQ/2509DA/3139).
Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy (8 AM - 11 PM).
Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by qualified genetic counselors.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Comprehensive EFCAB13 Gene Analysis for Autism Spectrum Disorder
The EFCAB13 Gene Autism Genetic Test examines the entire coding region of the EFCAB13 gene through Next Generation Sequencing, identifying pathogenic variants linked to Autism Spectrum Disorder and related neurodevelopmental phenotypes. This advanced diagnostic tool is essential for neurologists and medical researchers pursuing precision medicine in the UAE, offering definitive molecular confirmation to guide early intervention and familial risk assessment. يقوم هذا الفحص الجيني المتطور بتحليل شامل لجين EFCAB13 المرتبط باضطراب طيف التوحد باستخدام تقنية تسلسل الجيل التالي.
| Feature | Our Test (DHA-Licensed) | Closest Alternative |
|---|---|---|
| Precision | Single-Nucleotide Resolution via NGS | Microarray-Based CNV Detection (Limited Resolution) |
| Methodology | Next Generation Sequencing (Illumina Platform) | Whole Exome Sequencing (Broader, Less Targeted) |
| Turnaround Time | 3 to 4 Weeks (Rigorous Validation) | 6 to 8 Weeks (Standard Commercial Labs) |
Physician Insight & Safety Protocol
Clinical Note from Dr. Prabhakar Reddy (DHA License: 61713011): “As a neurologist practicing in the UAE, I emphasize that the EFCAB13 NGS test provides a critical piece of the diagnostic puzzle for autism, but it must be interpreted within the full clinical context. A negative result does not exclude an autism diagnosis, and a positive variant should be correlated with the patient's specific developmental history. This report empowers families with knowledge, but treatment decisions require a multidisciplinary approach.”
Medication Warning: Do not discontinue or alter any prescribed medication, including neuroleptics, antiepileptics, or behavioral therapies, based solely on this test result without explicit consultation with your treating physician.
Patient Safety: Exclusion Criteria & Emergency Red Flags
- Exclusion: Individuals unable to provide informed consent (including minors without guardian consent as per UAE CDS Law 2026).
- Exclusion: Patients with recent hematopoietic stem cell transplantation (within 90 days) — donor DNA may confound results.
- Emergency Red Flag: If you, or the individual tested, experience worsening self-harm or suicidal ideation, proceed immediately to the nearest Emergency Department. This genetic result does not constitute emergency psychiatric clearance.
- Emergency Red Flag: Development of new-onset seizures or status epilepticus following result disclosure requires immediate neurological evaluation.
Patient FAQ & Clinical Guidance
What does the EFCAB13 gene test detect, and how does it confirm an Autism Spectrum Disorder diagnosis?
The EFCAB13 NGS test detects single nucleotide variants, small insertions, and deletions within the EFCAB13 gene that have established pathogenic associations with Autism Spectrum Disorder. While it provides robust molecular confirmation, the diagnosis of autism remains a clinical one, based on comprehensive neurodevelopmental evaluation; a positive genetic finding substantiates etiology but cannot independently diagnose the condition without behavioral assessment.
كيف يتم سحب العينة لإجراء فحص جين EFCAB13، وما هي مدة ظهور النتائج في الإمارات؟
يتم سحب العينة بسهولة عبر قطرة دم على بطاقة FTA، أو من خلال سحب دم وريدي كامل بواسطة فريق التمريض المتنقل والمعتمد من هيئة الصحة، والذي يصل إلى منزلكم ضمن خدمة النقل المبرد. تستغرق النتيجة النهائية الكاملة ما بين ثلاثة إلى أربعة أسابيع، وتتضمن تقريراً سريرياً مفصلاً باللغتين الإنجليزية والعربية مع إمكانية استشارة طبية هاتفية بعد استلام التقرير.
Is a genetic counseling session mandatory before taking the EFCAB13 autism gene test?
Yes, a pre-test genetic counseling session to draw a detailed three-generation pedigree chart of family members affected with neurological or developmental conditions is mandatory and constitutes a critical pre-analytical requirement for accurate variant interpretation. Post- counseling is also provided to explain the implications of identified variants, potential familial risk, and reproductive options, all aligned with UAE Federal Decree-Law No. 41 of 2024 on human genetics.
Legal Compliance: This service complies with UAE Federal Decree-Law No. 41 of 2024 (Art. 87) on Genetic Testing, UAE PDPL (Federal Decree-Law No. 45 of 2021) for genomic data privacy, and the 2026 Commercial Data Sharing (CDS) Law governing minors' health data. Facility License: 9834453.
Methodology: Next Generation Sequencing (NGS) via Illumina Platform with 30x mean coverage, confirmed by Sanger Sequencing for reported variants.
Accreditation: ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139). DHA-MOHAP Standard Nomenclature Applied.
Support & Booking: +971 54 548 8731 | WhatsApp: +971 54 548 8731
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians